University of Minnesota
Minneapolis, Minnesota, 55455, United States
NCT Number: NCT05530590
This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlled trial will rigorously test the effects of an in person versus an online training program on improving SGM culturally responsive care with a waitlist control.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55455, United States
The study involves conducting a 3-arm, stratified (management/staff), group (agency) randomized controlled trial (RCT) of the in-person vs. online intervention vs. waitlist control on organizational factors (i.e., environment and policy) and on staff knowledge, attitudes, and skills.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants receive in person training.
Participants receive online training.
Time frame: baseline and 6-months follow up
Access to sexual and gender minority (SGM) providers, gender neutral intake forms
Time frame: Baseline
Ability to conduct 7 skills key to providing competent care to SGM
Time frame: Immediately post-intervention
Ability to conduct 7 skills key to providing competent care to SGM
Time frame: 6 months after intervention
Competent scale when it comes to providing care to SGM
Time frame: Baseline
Human Resources policies and intake forms
Time frame: 6 months post-intervention
HR policies and intake forms
Time frame: Baseline
10-item review of key content in training
Time frame: immediately post-intervention
10-item review of key content in training
Time frame: 6 months post-intervention
10-item review of key content in training
Time frame: Baseline
Homonegativity scale
Time frame: immediately post-intervention
Homonegativity scale
Time frame: 6 months post-intervention
Homonegativity scale
Time frame: Baseline
Jefferson Physician Empathy student version
Time frame: immediately post-intervention
Jefferson Physician Empathy student version
Time frame: 6 months post-intervention
Jefferson Physician Empathy student version
Time frame: Baseline
Adapted everyday discrimination scale
Time frame: immediately post-intervention
Adapted everyday discrimination scale
Time frame: 6 months post-intervention
Adapted everyday discrimination scale
Time frame: Baseline
Marlowe Crowne Social desirability scale
Time frame: immediately post-intervention
Marlowe Crowne Social desirability scale
Time frame: 6 months post-intervention
Marlowe Crowne Social desirability scale
Time frame: Baseline
Duke Religiosity Index
Time frame: 6 months follow-up post-intervention
Duke Religiosity Index
Time frame: Baseline
Agency type, size and staff
Time frame: Baseline and 6 month follow up.
Number of SGM staff
Time frame: 6 months follow up post-intervention
Number of SGM staff
University of Minnesota
Other
Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents
Acronym: MILLS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial DetailsNCT04121858
Alzheimer Disease, Brain Diseases
Indianapolis, Indiana, United States
View Trial Details